tradingkey.logo

Lisata Therapeutics And Catalent Announce Global Antibody-Drug Conjugate License Agreement

ReutersOct 8, 2025 1:01 PM

- Lisata Therapeutics Inc LSTA.O:

  • LISATA THERAPEUTICS AND CATALENT ANNOUNCE GLOBAL ANTIBODY-DRUG CONJUGATE (ADC) LICENSE AGREEMENT

  • LISATA THERAPEUTICS INC - TO RECEIVE OVER $10 MILLION IN MILESTONE PAYMENTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI